The University of Southampton
University of Southampton Institutional Repository

Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients

Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients
Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients
Background and objectives: There is currently little published guidance on the management of anticoagulant and antiplatelet medication in patients admitted with epistaxis. The routine practice of withholding such medication in an attempt to control the epistaxis is common in the UK. However, this practice is not evidence-based, is often unnecessary, and can be associated with significant morbidity. This study introduces a treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients, validated through a completed audit cycle. Methods: One hundred patients admitted with epistaxis to the University Hospital Southampton NHS Foundation Trust were studied via a two-audit cycle covering the implementation of a new treatment algorithm formulated jointly by the otolaryngology and haematology departments. Results: On admission, 58 per cent of patients were taking some form of anticoagulant or antiplatelet medication. The number of patients having such medication withheld decreased significantly between the two audits, for all drugs studied (i.e. aspirin, clopidogrel and warfarin). There was no significant increase in re-bleeding or re-admission rates between the audits. Conclusion: Implementation of this treatment algorithm would help standardise management for epistaxis patients taking anticoagulant or antiplatelet drugs, and should reduce morbidity associated with unnecessary routine discontinuation of such medication.
1-6
Biggs, T.C.
58983579-4acc-4207-bb3d-c7e62a17e2c7
Baruah, P.
b66bbf91-73c6-471b-9f86-30ef00a171b7
Mainwaring, J.
96deb63b-3fce-432b-affa-a5f67ffc9460
Harries, P.G.
b5e177a3-eb4d-4239-b0b5-968c39796fcf
Salib, R.J.
d6fde1c1-5b5e-43f7-ae1c-42cce6a0c9fc
Biggs, T.C.
58983579-4acc-4207-bb3d-c7e62a17e2c7
Baruah, P.
b66bbf91-73c6-471b-9f86-30ef00a171b7
Mainwaring, J.
96deb63b-3fce-432b-affa-a5f67ffc9460
Harries, P.G.
b5e177a3-eb4d-4239-b0b5-968c39796fcf
Salib, R.J.
d6fde1c1-5b5e-43f7-ae1c-42cce6a0c9fc

Biggs, T.C., Baruah, P., Mainwaring, J., Harries, P.G. and Salib, R.J. (2013) Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients. The Journal of Laryngology & Otology, 1-6. (doi:10.1017/S0022215113000492). (PMID:23544790)

Record type: Article

Abstract

Background and objectives: There is currently little published guidance on the management of anticoagulant and antiplatelet medication in patients admitted with epistaxis. The routine practice of withholding such medication in an attempt to control the epistaxis is common in the UK. However, this practice is not evidence-based, is often unnecessary, and can be associated with significant morbidity. This study introduces a treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients, validated through a completed audit cycle. Methods: One hundred patients admitted with epistaxis to the University Hospital Southampton NHS Foundation Trust were studied via a two-audit cycle covering the implementation of a new treatment algorithm formulated jointly by the otolaryngology and haematology departments. Results: On admission, 58 per cent of patients were taking some form of anticoagulant or antiplatelet medication. The number of patients having such medication withheld decreased significantly between the two audits, for all drugs studied (i.e. aspirin, clopidogrel and warfarin). There was no significant increase in re-bleeding or re-admission rates between the audits. Conclusion: Implementation of this treatment algorithm would help standardise management for epistaxis patients taking anticoagulant or antiplatelet drugs, and should reduce morbidity associated with unnecessary routine discontinuation of such medication.

Full text not available from this repository.

More information

e-pub ahead of print date: 2 April 2013
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 351368
URI: https://eprints.soton.ac.uk/id/eprint/351368
PURE UUID: 66342d1e-4fcc-4b8a-9b83-c3510be0d4f4
ORCID for R.J. Salib: ORCID iD orcid.org/0000-0002-6753-7844

Catalogue record

Date deposited: 19 Apr 2013 10:21
Last modified: 20 Jul 2019 01:02

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×